ID: 213347 Intrathecal Bupivacaine Slows Opioid Dose Escalation in a Low-Dose Intrathecal Opioid Pump Population

Abstract

Intrathecal drug delivery systems (IDDS) utilizing a low dose opioid strategy have proven durable in relieving pain without significant dose escalation (1). However, in a subset of patients, dose escalation is needed to maintain pain relief. Adjuvants such as bupivacaine are often used to augment pain relief in IDDS (2). We present a case series where bupivacaine was added to a low dose opioid strategy to slow the opioid escalation.